# Phase I Study of HXN6005 in Adult Healthy Participants

> **NCT07449741** · PHASE1 · RECRUITING · sponsor: **Helixon Biotechnology (Suzhou) Co., Ltd** · enrollment: 32 (estimated)

## Conditions studied

- Healthy Volunteers (HV)

## Interventions

- **DRUG:** HXN6005
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07449741
- **Lead sponsor:** Helixon Biotechnology (Suzhou) Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-27
- **Primary completion:** 2027-03-13
- **Final completion:** 2027-03-13
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07449741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07449741, "Phase I Study of HXN6005 in Adult Healthy Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07449741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*